在Apolipoprotein E促进体内一个新的G-四重复结构:在癌症和痴呆症斗争中一个新的有前途的目标?
Valentina Pirota1,2, Angela Dello Stritto3, Lisa Rita Magnaghi1,4
1Department of Chemistry, University of Pavia, via Taramelli 10, I-27100 Pavia, Italy.
ACS omega
|November 18, 2024
概括
研究人员在人类的阿波利波蛋白E (APOE) 基因促进器中发现了一个G-四重复 (G4) 结构. 这一发现为调节癌症和阿尔茨海默病 (AD) 中的APOE表达提供了一个新的治疗标.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 人类阿波利波蛋白E (APOE) 对于脂质运输至关重要,并与癌症和阿尔茨海默氏病 (AD) 有关.
- 调节APOE表达是一种潜在的治疗策略,用于癌症和AD.
- G-四重复 (G4) 结构是药物化学中基因表达的关键调节者.
研究的目的:
- 识别和描述人类阿波利波蛋白E (APOE) 基因促进体内的G-四重复 (G4) 结构.
- 探索针对这些G4结构用于治疗APOE表达的调制的潜力.
主要方法:
- 生物信息分析以确定APOE促进体中的潜在G4形成序列.
- 生物物理技术包括循环二重化,NMR光谱和紫外线化来确认G4折叠.
- 定量PCR停止测定和使用G4稳定配体和破坏性核酸合物.
主要成果:
- 在APOE促进体中发现并证实了稳定的平行G-四重复 (pApoE-G4).
- 稳定G4联体增强了pApoE-G4结构的热稳定性.
- 酸核酸结合物被证明可以破坏G4的形成,展开结构.
结论:
- 这项研究在人类APOE基因促进器中呈现了一种新的G-四重复 (G4) 结构.
- 这一发现为开发针对ApoE-G4s调节APOE表达的治疗策略提供了基础.
- 准APOE-G4s对促进癌症和阿尔茨海默病 (AD) 治疗的进展具有前途.
相关概念视频
The Eukaryotic Promoter Region
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


